NCT02030769View on ClinicalTrials.gov

Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer

NACompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Esophageal Neoplasms
Interventions
DRUG

Pronase

use pronase to improve visibility during endoscopical iodine staining

DRUG

Control

No pronase plus Dimethicone and sodium bicarbonate. use without pronase to compare visibility during endoscopical iodiine staining

Trial Locations (1)

710032

Xijing Hospital of Digestive Disease, Xi'an

All Listed Sponsors
collaborator

Beijing Tide Pharmaceutical Co., Ltd

INDUSTRY

lead

Xijing Hospital of Digestive Diseases

OTHER

NCT02030769 - Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer | Biotech Hunter | Biotech Hunter